These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38148473)

  • 1. An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits.
    Kilaru R; Amodio S; Li Y; Wells C; Love S; Zeng Y; Ye J; Jelizarow M; Balakumar A; Fronc M; Osterdal AS; Rolfe T; Talbot S
    Ther Innov Regul Sci; 2024 Mar; 58(2):273-284. PubMed ID: 38148473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
    Bhagat R; Bojarski L; Chevalier S; Görtz DR; Le Meignen S; Makowski M; Nadolny P; Pillwein M; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Mar; 55(2):251-261. PubMed ID: 32885397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
    Makowski M; Bhagat R; Chevalier S; Gilbert SA; Görtz DR; Kozińska M; Nadolny P; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Nov; 55(6):1265-1273. PubMed ID: 34453269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality Tolerance Limits' Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters.
    Wolfs M; Bojarski Ł; Young S; Cesario L; Makowski M; Sullivan LB
    Ther Innov Regul Sci; 2023 Jul; 57(4):839-848. PubMed ID: 36972010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Renovation of Good Clinical Practice: A Framework for Key Components of ICH E8.
    Whitehead M; Suprin M; Mistree T; Kearns MM; Marini G; Goffe C; Pillwein M; Abdul-Shukkoor V
    Ther Innov Regul Sci; 2024 Mar; 58(2):303-310. PubMed ID: 38038888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting.
    Keller A; van Borrendam N; Benner P; Gilbert S; Saino S; Jendrasek D; Young S; Muli M; Wang J; Kozińska M; Liu J
    Ther Innov Regul Sci; 2024 May; 58(3):423-430. PubMed ID: 38321191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
    Phillips A; Clark T
    Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the effectiveness of a risk-based monitoring approach implemented with clinical trials involving implantable cardiac medical devices.
    Diani CA; Rock A; Moll P
    Clin Trials; 2017 Dec; 14(6):575-583. PubMed ID: 28819983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Question-based review for pharmaceutical development: An enhanced quality approach.
    Simões A; Veiga F; Vitorino C
    Eur J Pharm Biopharm; 2024 Feb; 195():114174. PubMed ID: 38160986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributes.
    Montes RO
    Pharm Stat; 2024; 23(2):168-184. PubMed ID: 37871968
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.